Daniel Byrnes

Daniel Byrnes is an experienced executive in market access operations and strategy within the pharmaceutical and biotechnology sectors. Currently serving as Executive Director of Market Access Operations at Arcutis Biotherapeutics, Inc. since June 2023, Byrnes previously held the position of Executive Director of Strategy at Ortho Dermatologics from December 2021 to June 2023. Prior roles include Senior Director of Patient Access Solutions and various director-level positions at Bausch Health Companies Inc. from August 2017 to December 2021, as well as multiple finance roles at Valeant Pharmaceuticals between October 2013 and August 2017. Byrnes began a career in finance as a Senior Associate at PricewaterhouseCoopers from July 2010 to October 2013. Byrnes holds a Bachelor of Science degree in Accounting and Economics from The College of New Jersey.